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Abstract 
Background 
The accessibility from online sources of Adderall (amphetamine/dextroamphetamine), a controlled 
substance with harmful adverse events if abused or misused, and rapid-acting insulins (Humalog (insulin 
lispro) and NovoLog (insulin aspart)), high-risk medications with an outsized role in the public debate 
regarding high drug prices, have not been well documented. There is concern that some patients might 
choose online pharmacies for a host of reasons, including ease of access, privacy, or cost-savings, unaware 
that 96% of online pharmacies are illegitimate. Patients who purchase medications from illegitimate online 
pharmacies remove themselves from traditional healthcare systems that ensure safe and effective drug use. 
In addition, patients using illegitimate online pharmacies are at risk of receiving low-quality medications.  
 
Objectives 
Assess the availability of Adderall, Humalog, and NovoLog from common search engines, and evaluate 
the safety and marketing characteristics of online pharmacies selling these medications.  
 
Methods 
From September 2019 to February 2020, the phrases ‘buy Adderall online,’ ‘buy Humalog online’, ‘buy 
NovoLog online’, and ‘buy insulin online’ were queried in four unique search engines. For each query, the 
first 100 results of Google and Bing, and the first 50 results of Yahoo and DuckDuckGo were screened. 
Online pharmacies that claimed to sell the queried medication (e.g., Adderall, Humalog, or NovoLog), had 
unique uniform resource locations (URLs), were active, free-access, and in English language were included. 
Online pharmacies were categorized as rogue, unapproved, unclassified, or legitimate based on LegitScript 
classifications. Safety, marketing characteristics, and costs were collected. The analyses of Adderall and 




Of 62 online pharmacies found to sell Adderall, 61 were rogue or unclassified. Across all rogue and 
unclassified online pharmacies, prescriptions were not required (100%), pharmacist services were not 
offered (100%), and quantity limits were not placed on the number of Adderall units purchased (100%). 
Rogue and unclassified online pharmacies appealed to cost, claiming price discounts (61%), providing bulk 
discounts (67%), and offering coupon codes (70%). Contrary to these claims, cheaper prices were available 
from GoodRx than from rogue and unclassified online pharmacies across all formulations and strengths of 
Adderall. Rogue and unclassified online pharmacies promoted and enabled the illicit purchase of Adderall, 
appealing to privacy (74%), offering purchase through cryptocurrency (74%), and claiming registration or 
accreditation of their sites (33%).  
 
Insulin 
Of the 49 online pharmacies found to sell Humalog or NovoLog, 60% were illegitimate (e.g., rogue or 
unapproved). From these pharmacies, Humalog and NovoLog were 2-5 times cheaper as compared to 
legitimate online pharmacies. Risks associated with the use of illegitimate online pharmacies were evident 
in that, of the online pharmacies that shipped within the U.S. (including rogue and unapproved), 60% did 
not require a prescription, 47% did not display drug warnings or information, and only 20% offered access 
to a purported pharmacist. 
 
Conclusion 
Illegitimate online pharmacies are pervasive in search engine results, enabling the illicit purchase of 
Adderall, Humalog, and NovoLog without a prescription. There is concern that patients might purchase 
these medications from illegitimate online sources—knowingly or not—for perceived ease of access, 
privacy, lower cost, or other ‘perks’ that illegitimate online pharmacies claim. Law enforcement, regulatory 
agencies, healthcare professionals, and search engines should work to further protect consumers from 
illegitimate online pharmacies selling prescription medications like Adderall and rapid-acting insulins.    
Background 
Online pharmacies have emerged as a popular destination for the purchase of prescription drugs. Though 
the overall volume varies on a daily basis, 30,000-35,000 accessible online pharmacy websites were found 
to be accessible in 2016.1 Online pharmacies can be defined by whether they operate as legitimate and 
registered pharmacies or whether they are illegitimate and in violation of U.S. pharmacy laws and practice 
standards.2 According to LegitScript, a verification and monitoring service, 96% of all accessible online 
pharmacies are illegitimate, of which 92% are rogue, meaning that they sell drugs without a valid 
prescription.1 Given the high prevalence of rogue online pharmacies, the ease of access to high-risk 
medications and medications of abuse is of particular concern.  
 
National organizations have been combatting the proliferation of illegitimate online pharmacies. The Food 
and Drug Administration’s (FDA) BeSafeRx campaign and the Alliance for Safe Online Pharmacies’ 
(ASOP) ‘Buy Safe Rx’ campaign empowers consumers by raising awareness of the dangers of purchasing 
medications from illegitimate online pharmacies, as well as providing information on the warning signs 
that an online pharmacy might be operating illegally.3,4 The National Association of Boards of Pharmacy 
(NABP) lists accredited digital pharmacies on its website.5 NABP also offers a verification service for 
legitimate online pharmacies through which they can receive a ‘.pharmacy’ domain, increasing consumers’ 
visibility of legitimate pharmacies. LegitScript allows consumers to enter a uniform resource location 
(URL) to determine a pharmacy’s legitimacy.6 Moreover, regulatory and legal actions beyond raising public 
awareness are ongoing against illegitimate online pharmacies. Operation Pangea, a cooperative effort led 
by Interpol in conjunction with the FDA and US Department of Justice (DOJ) has led to the removal of 
thousands of illegitimate online pharmacies.7 LegitScript has also partnered with the FDA to identify and 
close illegitimate online pharmacies. Still, illegitimate online pharmacies remain challenging to control, as 
there are innumerable URLs under which they can operate. 
 
Despite these organizational attempts, illegitimate online pharmacies remain pervasive and many 
consumers remain unaware of the associated dangers. In choosing illegitimate online pharmacies, 
consumers opt out of medication counseling, monitoring, and drug-drug interaction checking that 
pharmacists and healthcare professionals offer.8 The utilization of such resources in healthcare has been 
shown to improve patient outcomes.9 Concerns regarding insufficient safety measures are further 
exacerbated by the marketing methods that illegitimate online pharmacies use to attract consumers.10,11 
Though it has been shown that patients using no-prescription online pharmacies are at greater risk of 
developing treatment-related adverse events, there is a lack of current data on how illegitimate online 
pharmacies approach patient safety and what marketing methods they employ, particularly for medications 
of high risk and abuse potential.12  
 
Adderall 
Adderall (amphetamine/dextroamphetamine) is a central nervous system (CNS) stimulant medication 
commonly used to treat attention-deficit/hyperactivity disorder (ADHD). Though effective in its treatment 
of ADHD, Adderall carries a high potential for abuse and dependence—its non-medical use among college 
students for neurocognitive enhancement has been well-documented, with a prevalence estimated from 
9-23%.13-15 Overall non-medical use of prescription stimulants has been estimated at around 8% in adults.16 
Inherent to the abuse of amphetamines are risks including weight loss, cardiovascular events, psychological 
dependence, and morphological brain changes.17-22 Due to its high potential for abuse, which could lead to 
severe psychological or physical dependence, Adderall is classified by the U.S. Drug Enforcement 
Administration (DEA) as a schedule II medication.23   
 
Insulin 
For patients with Type 1 or Type 2 advanced diabetes, insulin is a cornerstone of therapy. One in ten 
Americans (around 34.2 million people) have diabetes, with nearly 1.6 million living with Type 1 
diabetes.24 Patients with Type 1 diabetes cannot produce endogenous insulin and thus require treatment 
with exogenous insulin. For patients living with Type 2 diabetes, insulin is often required if they cannot 
maintain adequate glycemic control with lifestyle modifications and non-insulin medications. In those 
patients who require insulin, regulation of blood glucose is tantamount to disease control—if uncontrolled, 
it can result in the acute, life-threatening conditions of diabetic ketoacidosis or severe hypoglycemia, as 
well as chronic but still life-threatening complications like cardiovascular disease, nephropathies, 
retinopathies, and neuropathies.25 These complications can result in—among other outcomes—dialysis-
dependence, blindness, amputations, serious quality-of-life reductions, and death.25 
 
Increasingly, rising costs unique to the U.S. market have hindered access to insulin for patients.26 Despite 
legislative initiatives to control prescription drug costs, high insulin costs in the U.S. persist, with list prices 
of insulin tripling from 2003 to 2013.26 While insulin was first used as a medication in 1922, the insulin 
market remains dominated by branded products, with no actual generic drug approved. Generic competition 
has been shown to decrease drug prices by 60%, on average, when 3 generic manufacturers are in the 
market.27 High costs are associated with all insulin types, but rapid-acting insulin analogues like Humalog 
(insulin lispro) and NovoLog (insulin aspart) are among the highest priced.26 Humalog’s list price, for 
example, continued to increase after 2014 from $391 to nearly $600 in 2017—a list price increase similar 
to that of its competitor NovoLog. It is worth noting that net prices remained relatively stable for Humalog 
and NovoLog during that timeframe, meaning increase in costs were primarily offset by discounts made 
available.28 Regardless, high list prices have a direct impact on patients—in 2019, 1-in-4 patients in the 
U.S. with Type 1 diabetes reported difficulties affording their medication.29 Patients like this are often led 
to make difficult decisions—in 2019, more than 1-in-4 patients in the U.S. with Type 1 diabetes reported 
rationing their insulin.30 Patients who struggle to access insulin from traditional methods, namely brick-
and-mortar pharmacies, might look to alternative, lower-cost methods, such as purchasing insulin from 
friends, across borders, or from illegitimate online pharmacies.31,32  
 
The accessibility of Adderall and rapid-acting insulins from illegitimate online sources is a public health 
hazard. We investigated the availability of these medications from online pharmacies through search results 
of common search engines and documented the websites’ safety and marketing characteristics, as well as 
costs of Adderall, Humalog, and NovoLog.   
 
Methods 
Website selection was conducted from September 2019 to February 2020 using four different search 
engines (Google, Bing, Yahoo, and DuckDuckGo) with the phrases ‘buy Adderall online’, ‘buy Humalog 
online’, ‘buy NovoLog online’, and ‘buy insulin online’. Two distinct analyses were performed on results 
for Adderall and results for rapid-acting insulins. The four queried search engines were chosen based on 
user traffic and, for DuckDuckGo specifically, its emphasis on user privacy. Search algorithms on these 
websites incorporated synonyms of search terms. The first 100 results of Google and Bing and the first 50 
of Yahoo and DuckDuckGo were screened for each medication, incorporating more results from popular 
search engines. Websites were included if they claimed to sell the queried medication, were active websites, 
free to access, in English language, and had a unique URL. For Adderall, information for websites selling 
either Adderall immediate release (IR) or Adderall extended release (XR) were collected, as these products 
contain the same active ingredient (amphetamine/dextroamphetamine). For Humalog and NovoLog, 
information for websites selling any formulation (e.g., vials, pens, or cartridges) were collected. Websites 
that required one extra click to reach the website selling the medication were also included. Screenshots 
were taken of website pages to ensure the internal validity of results.  
 
The legitimacy of websites was assessed using LegitScript, a verification and monitoring service that has 
monitored more than 70,000 online pharmacies.6 Among other criteria, LegitScript classifies pharmacies 
depending on: licensure or registration in affiliated jurisdictions, sale of controlled substances, prior 
discipline, requirement of valid prescription, protection of privacy, patient services offered, transparency, 
and domain name registration.33 Websites in this analysis were classified as LegitScript defines them: 
rogue—‘these merchants engage in illegal, unsafe, or misleading activities like selling prescription drugs 
without a prescription’; unapproved—‘these merchants have some problem with regulatory compliance or 
risk, but it is typically less egregious than ‘rogue’, legitimate—‘these merchants are registered with a 
LegitScript certification program and have passed LegitScript certification criteria’; or unclassified—no 
information was available from LegitScript.34 For the analysis of rapid-acting insulins, rogue and 
unapproved are often referred to collectively as illegitimate online pharmacies.  
 
The average monthly traffic to website domains defined as unique visits from any country was obtained 
using www.SimilarWeb.com. This website aggregates information on website traffic from a variety of 
sources including open exchange of first-party data and surveying public data sources. The internet protocol 
(IP) addresses of websites were checked using www.IP2location.com, which retrieves geographical 
information based on IP addresses. Registered geographic locations of the IP addresses were compared to 
listed website locations. 
 
Safety 
Characteristics related to safety were selected based on previous literature and obtained from each included 
website.2,8,10,35,36 Characteristics were compared across rogue, unclassified, and legitimate online 
pharmacies. For insulins, to allow for a specific focus on U.S. pharmacies, safety characteristics were 
analyzed only for online pharmacies that offered shipping within the U.S. For both Adderall and insulins, 
basic pharmacy-related safety characteristics included the requirement of a prescription, controls on the 
amount of medication that could be ordered (e.g., restricting patients to a 90-day supply). Characteristics 
related to pharmacy services included whether there was an offer to speak with a pharmacist, and whether 
drug information and drug-related warnings and precautions were displayed on the product page. 
Characteristics related to location included whether the pharmacy listed a physical location and the website 
location listed vis-à-vis IP address location (and whether it matched the location listed). For Adderall alone, 
requirement of a health-related questionnaire was also assessed.  
 
Marketing 
Characteristics related to marketing were selected based on previous literature.2,8,10,11,35,36 Marketing 
characteristics were compared across online pharmacy type. For both Adderall and insulins, cost-related 
marketing characteristics included whether online pharmacies offered bulk discounts or ‘promo codes’ on 
checkout or claimed a ‘discount’ compared to other pharmacies. Promotional marketing characteristics 
included whether online pharmacies displayed specific drug advertisements pertaining to any form of 
Adderall or insulin, advertisements for other products on the page advertising the queried medication, or 
customer testimonies. Marketing characteristics appealing to customer service and general reputability 
included whether online pharmacies displayed a phone number, offered the assistance of an associate, or 
claimed pharmacy registration in some form (e.g., Canadian International Pharmacy Association (CIPA); 
International Pharmacy Association of British Columbia (IPABC); etc.). Additional marketing 
characteristics included whether online pharmacies offered privacy reassurances (e.g., discrete packaging 
or protection of health- or billing-related information) or offered shipping within the U.S. For Adderall, 
additional collected marketing characteristics included whether the online pharmacy facilitated purchases 
using cryptocurrency (e.g., Bitcoin). For insulins, shipping within the U.S. was assessed. In addition, to 
examine specific marketing language for insulins, we collected text from the homepages of included online 
pharmacies. After initial inspection to identify the most common marketing language, the text was screened 
to determine whether the following characteristics were discussed: (i) quality; (ii) safety; (iii) customer 
service; (iv) reputability; (v) affordability; and (vi) convenience. These characteristics were defined and 
quotes representative of each characteristic and pharmacy type were collected.  
 
Cost 
Price and shipping costs of Adderall IR and Adderall XR 30 mg at the most frequently sold quantities of 
60, 90, 120, 180, and 240 were collected. Price per tablet or capsule of Adderall IR and Adderall XR were 
calculated accounting for shipping costs. For Adderall, shipping costs were distributed among the total 
quantity of pills or capsules in an order. Costs of Humalog and NovoLog 100 IU/mL insulin at the most 
frequently sold dosage forms (i.e., 1x10 mL vials, 5x3 mL pens, 5x3 mL cartridges) were collected form 
online pharmacies that offered to ship within the U.S. Price per mL of 100 IU/mL Humalog and NovoLog 
for vials, pens, and cartridges was calculated. For insulins, shipping costs and bulk discounts were not 
considered in the cost calculations. For both Adderall and insulins, online pharmacy prices were compared 
to prices offered through GoodRx, an online prescription drug coupon site, which is what a U.S. consumer 




Through searching Google, Bing, Yahoo, and DuckDuckGo with the query ‘buy Adderall online,’ we 
identified a total of 62 online pharmacies claiming to sell Adderall (Figure 1). Of these online pharmacies, 
LegitScript classified 50 as rogue, while 11 were unclassified (i.e., no information about those sites were 
available through LegitScript), and 1 site was legitimate. Traffic to these websites, as determined by 
www.SimilarWeb.com, differed depending on classification as outlined in Figure 2. The traffic to rogue 
and unclassified websites was low, with the majority receiving <5000 unique monthly visits. Monthly 
traffic of the one legitimate website was comparatively much larger at 1-2 million unique monthly visits.  
 
Safety characteristics of all online pharmacies selling Adderall are described in Table 1. Among rogue and 
unclassified pharmacies, prescriptions and health-related questionnaires were not required (100%), none 
offered pharmacist services (100%), and none placed a quantity limit on the number of Adderall that could 
be ordered (100%). Rogue and unclassified pharmacies commonly offered some form of drug 
warning/precautions (64%), and nearly uniformly provided some form of drug information (89%). The 
location of rogue and unclassified online pharmacies was not listed on nearly half (49%) of their websites. 
Overall, the locations listed on rogue and unclassified online pharmacy websites were not consistent with 
the locations of their servers as determined by www.IPLocation.net (80%). Server locations and respective 
website-listed locations of online pharmacies in our sample are depicted in Figure 3.  
 
Marketing characteristics of all online pharmacies selling Adderall are described in Table 2. Rogue and 
unclassified online pharmacies often made cost arguments by claiming a price discount compared to other 
pharmacies (61%), providing bulk discounts (67%), and offering coupon on promotion codes (70%). Other 
marketing characteristics included the use of advertisements in various forms: customer testimonies (66%); 
Adderall-specific ads (31%); and ads for other products on the product page (84%). Rogue and unclassified 
online pharmacies stressed their accessibility by offering a phone number or WhatsApp contact information 
(82%), and nearly uniformly offered customers to speak with an associate through a ‘Contact Us’ page or 
chat feature (98%). Privacy was stressed – rogue and unclassified online pharmacies provided privacy 
assurances on either patient information or ‘discreet package delivery’ (74%). Privacy was also offered by 
accepting cryptocurrency such as Bitcoins (74%). Rogue and unclassified online pharmacies often declared 
some form of registration or verification through varied accrediting bodies and agencies such as the PCCA 
or NABP Digital Pharmacy Accreditation, in turn suggesting product quality and safety (33%).  
 
For rogue and unclassified online pharmacies, the cost per tablet of Adderall IR and cost per capsule of 
Adderall XR at quantities of 60, 90, 120, 180, and 240 are displayed in Figure 4. At all quantities, prices 
for Adderall IR and Adderall XR online were greater than the price offered through the coupon site GoodRx.  
 
The singe legitimate website (www.humanapharmacy.com) required a prescription, offered pharmacist 
services, and placed a limit on quantity of Adderall that could be sold, as determined by the quantity written 
on the prescription. Drug warnings/precautions, drug information, and price for Adderall could not be 
observed on this site because consumers were unable to advance without a member ID and prescription. 
The marketing characteristics of the legitimate website did not place an emphasis on price (there were no 
listed price or bulk discounts) but did emphasize accessibility with a phone number listed and an offer to 
speak with an associate. The legitimate website offered privacy assurances and advertised its registration 
and accreditation with NABP, Utilization Review Accreditation Commission (URAC), and Accreditation 
Commission for Health Care (ACHC). 
 
Insulin 
We screened 300 websites and identified a total of 49 online pharmacies that claimed to sell Humalog or 
NovoLog (Figure 5). Of the online pharmacies, LegitScript classified 29 (59%) as illegitimate (18 (37%) 
rogue and 11 (22%) unapproved) and 7 (14%) as legitimate, while 13 (27%) were unclassified. The listed 
location of these online pharmacies differed, with 12 illegitimate online pharmacies (rogue N=12; 
unapproved N=0) that advertised no location. Of the 29 illegitimate online pharmacies, 15 advertised a 
Canadian location (rogue N=4; unapproved N=11). The remaining illegitimate online pharmacies claimed 
a Great Britain (N=1), Europe (N=1) location. No illegitimate online pharmacies advertised a US location. 
For legitimate online pharmacies, 3 advertised locations in the U.S., 2 in Australia, 1 in Canada, and 1 in 
India. Physical locations listed on websites were compared to server locations, as determined by 
www.IPLocation.net. All legitimate online pharmacies’ physical locations listed on their websites matched 
that of their server locations. Whereas, illegitimate online pharmacies classified as unapproved had a 
matching physical and server location 40% of the time, while illegitimate online pharmacies classified as 
rogue had no matching physical to server locations.  
 
Traffic to online pharmacies, as determined by www.SimilarWeb.com, differed depending on 
classification. Though illegitimate online pharmacies were the most abundant online pharmacy type in the 
search results, unique monthly visits were comparatively lower to illegitimate online pharmacies (0 to 
250,000) than to legitimate online pharmacies (5000 to 63.6 M). The 3 U.S.-based legitimate online 
pharmacies received the highest volumes of unique monthly traffic—1.17 M (healthwarehouse.com), 40.35 
M (cvs.com), and 63.6 M (costco.com).   
 
Safety characteristics of online pharmacies selling Humalog and NovoLog within the U.S. are described in 
Table 3. Rogue online pharmacies differed from legitimate online pharmacies more substantially than 
unapproved online pharmacies. Rogue online pharmacies seldom required a prescription (10%) or placed 
quantity limits on amount of medication ordered (10%), and none offered pharmacist services (0%). 
Unapproved online pharmacies uniformly claimed to require a prescription (100%) and placed quantity 
limits (100%), and some sites offered pharmacist services (60%). For both rogue and unapproved online 
pharmacies, drug-related warnings and information were not uniformly displayed. Though data was 
unavailable for one legitimate online pharmacy regarding whether pharmacist services were offered (a 
member registration was required), and not all legitimate online pharmacies were accredited through the 
NABP due to geography, legitimate online pharmacies required or displayed characteristics consistent with 
best online pharmacy communication practices such as requiring pharmacists to offer interactive, 
meaningful consultation.5 
 
Marketing characteristics of online pharmacies selling Humalog and NovoLog are described in Table 4. 
Rogue online pharmacies differed from unapproved and legitimate online pharmacies in several 
characteristics—more often, they offered bulk discounts (61%), assured privacy (78%), and promoted other 
products on the Humalog® or NovoLog® insulin product page (72%). Though rogue online pharmacies 
offered some form of contact through e-mail or a chat function, a majority did not offer a phone number 
(61%). Both legitimate and unapproved online pharmacies shared similar characteristics—few offered bulk 
discounts (29% legitimate; 18% unapproved), all displayed a phone number (100%), and most touted 
registration or accreditation claims (86% legitimate; 91% unapproved). 
 
Marketing language from website homepages differed among online pharmacy type for certain 
characteristics—83% of illegitimate online pharmacies appealed to quality (vs 29% of legitimate), safety 
66% vs 14%, and customer service 83% vs 57%, respectively. The marketing language was similar among 
reputability (55% vs 57%), affordability (83% vs 71%), and convenience (76% vs 71%). Differences in 
marketing language were quantified and demonstrated with select quotes in Table 5. The advertising 
language of illegitimate online pharmacies tended to communicate an urgency of purchase and emphasized 
the merits of the pharmacy. For example, one quote from an illegitimate online pharmacy appealed to 
reputability, affordability, and safety: 
 
“If you are looking to buy your prescription drugs in Canada, through a reputable 
international or online Canadian pharmacy, [our online pharmacy] provides you access to 
a trusted source of affordable and safe prescription drugs.” 
 
The costs of Humalog and NovoLog vials, pens, and cartridges were observed for online pharmacies 
shipping within the U.S. (N=23 including unclassified online pharmacies). The most common volume and 
strength of insulin vials was 10 mL at 100 IU/mL. Humalog and NovoLog 3 mL pens and 3 mL cartridges 
were most often sold in packages containing a quantity of 5, which is in alignment with product packaging 
available from brick-and-mortar pharmacies. Cost per mL of 100 IU/mL insulin varied depending on the 
type of online pharmacy. For rogue online pharmacies, the cost of insulin varied depending on dosage form: 
Humalog vials $11.30 (N=1), Humalog pens $7.84 (N=4), Humalog cartridges $10.04 (N=4), NovoLog 
vials $5.90 (N=2), NovoLog pens $7.69 (N=8), NovoLog cartridges $8.00 (N=3). Costs were similarly low-
cost in unapproved and unclassified online pharmacies. For legitimate online pharmacies, the cost of insulin 
(without insurance) was 2-5-fold higher depending on dosage form: Humalog vials $31.51 (N=2), Humalog 
pens $38.89 (N=2), Humalog cartridges (N=0), NovoLog vials $32.77 (N=2), NovoLog pens $40.77 (N=2), 
NovoLog cartridges $38.47 (N=2). Compared to illegitimate pharmacies, GoodRx costs were also 
approximately 2-5 times more expensive, whereas compared to the cost from legitimate pharmacies (for 
uninsured patients), GoodRx prices were marginally cheaper: Humalog vials $17.22, Humalog pens $21.83, 
Humalog cartridges $34.13, NovoLog vials $29.38, NovoLog pens $37.31, NovoLog cartridges $35.90. 
The difference in cost per mL of Humalog and NovoLog pens (the most common dosage form in our 




We found that the vast majority of online pharmacies selling Adderall were rogue or unclassified by 
LegitScript. Of 62 online pharmacies claiming to sell Adderall, only one was a legitimate seller. By not 
requiring a prescription, rogue pharmacies allow the purchase of medications that could be abused, enabling 
the ill-advised practice of Adderall use without concurrent therapeutic monitoring.  
 
With high doses and repeated use of Adderall, the development of psychological amphetamine dependence 
and adverse events such as weight loss, psychosis, seizures, and cardiovascular events can occur.17,18 
Though data is sparse, morphological brain changes and related behavioral alterations—particularly in 
adolescents with prolonged amphetamine use—are also a concern.19-21 In addition, though we did not 
conduct an analysis on drug quality, it is documented that illegitimate online pharmacies frequently sell 
substandard and falsified medications.36 Consumers with and without valid prescriptions face risks when 
purchasing from illegitimate online pharmacies. Those with a valid prescription might receive poor quality 
medication and be harmed by impurities, fail to achieve therapeutic goals, and suffer from a lack of 
therapeutic monitoring. Those without a valid prescription, who might be more inclined to abuse Adderall 
and take more than the necessary dose, are predisposed to the same risks as those with a prescription, as 
well as the potential for an increased frequency of dose-dependent adverse effects.  
 
Concerns related to the purchase of Adderall from rogue online pharmacies are amplified by the marketing 
characteristics that these pharmacies employ. As evinced in these pharmacies not placing quantity limits on 
the amount of Adderall for purchase, rogue online pharmacies intend to sell as much of these products as 
possible. The sale of Adderall is achieved through varied selling arguments—the appeal to cost-savings, 
constant customer support, and privacy, which are perhaps the most important selling arguments for 
consumers who intend to purchase controlled substances without a prescription. Rogue online pharmacies 
in the sample appealed to discrete package delivery, protection of patient information, and the use of de-
identified forms of payments involving cryptocurrency. These selling arguments, which are designed to 
lure consumers into purchasing more medications, run counter to reasonable patient care and sensible 
legislation that aims to protect the public from drugs of abuse and misuse.  
 
Previous studies comparing prescription drug prices between online and brick-and-mortar pharmacies have 
had mixed results depending primarily on the drug studied, with several finding lower costs online.38,39 Our 
investigation into the cost of Adderall IR and Adderall XR from rogue online pharmacies revealed that 
marketing language detailing ‘affordability’ was not necessarily true for the purchase of Adderall without 
a prescription. Compared to prices listed on GoodRx, a popular coupon site for patients purchasing 
medications without insurance, rogue online pharmacy prices including shipping costs for Adderall IR and 
Adderall XR were nearly 5-fold more expensive per unit. The steep price differential is suggestive of the 
illegal nature of Adderall purchase without a prescription online. From a cost standpoint, patients with a 
valid prescription have little incentive to purchase Adderall from a rogue online pharmacy. This result 
supports existing literature that among online pharmacies, there is a price markup for the purchase of 
medications without a prescription.11 Our results demonstrate that the no-prescription price differential 
extends to brick-and-mortar pharmacies, which offer cheaper medications. 
 
Unfortunately, despite governmental and organizational attempts to quell their proliferation, rogue online 
pharmacies are challenging to control as they regularly re-emerge. Though the overall web traffic to rogue 
online pharmacies in our results was relatively low (Figure 2), this could be suggestive of the methods that 
rogue online pharmacies use to avoid detection, regularly closing and opening new websites under unique 
URLs. This is supported by our finding that geographic locations listed on rogue and unclassified online 
pharmacy websites were largely (80%) not consistent with locations of their servers. These results 
demonstrate that search engines are not effectively screening for and removing rogue online pharmacies 
from their search results at present. In the absence of efficient methods to regulate and remove rogue online 
pharmacies, it is imperative that search engines acknowledge the pervasiveness of rogue online pharmacies 
within their search results and take additional measures of control. Search engines should help lead the 
effort to create a safer online pharmacy landscape through the generation of search algorithms that select 
for legitimate online pharmacies.  
 
Insulin 
Our analysis demonstrates that both Humalog and NovoLog are readily available from online pharmacies 
that engage in the illegal sale of prescription drugs. Illegitimate (i.e., rogue and unapproved) online 
pharmacies were abundant in the results of common search engines, outnumbering the legitimate online 
pharmacies. Of the unique online pharmacies that we included in our analysis, nearly 60% were illegitimate, 
while only 14% were legitimate (with the remainder being unclassified). The relative prevalence of 
illegitimate online pharmacies poses a threat to unsuspecting consumers and provides easy access to those 
seeking insulin without a prescription.32 The incentive to purchase insulin from illegitimate online 
pharmacies goes beyond ease of access, as our analysis reveals that these online pharmacies offer 
substantial price reductions as compared to brick-and-mortar and legitimate online pharmacies. 
 
In the U.S., rising list prices on rapid-acting insulin analogues like Humalog and NovoLog have resulted in 
substantial cost burdens for patients with diabetes. Legislative initiatives to curb insulin costs include, 
among others, out-of-pocket maximums and personal drug importation. However, these reforms have only 
been trialed on the state level and not federally, and the legality of personal importation of insulin remains 
contentious.40,41 In 2018, in the midst of public outcry at high insulin costs, the manufacturer Eli Lilly 
introduced Lispro, an authorized generic to Humalog, at a 50% discount to the Humalog list price.42 
Unfortunately, according to a Senate report, the uptake of Lispro has been meager at best, with 83% of 386 
surveyed national pharmacies not having Lispro in stock and 69% unable to order the drug.43 In 2020, the 
Trump Administration announced that Medicare would begin offering 1,750 insurance plans that capped 
out-of-pocket spending to $35 for insulin.44 However, this out-of-pocket maximum is limited to Medicare 
beneficiaries. Given relatively limited action from the federal government, manufacturers, and other key 
players in the U.S. pharmaceutical supply chain, high insulin list prices and out-of-pocket costs for many 
persist, and patients continue to have access problems, particularly those who are uninsured—which in 
2018 made up 8.5% of the U.S. population—or have a high deductible insurance plan.26,45 
 
With financial pressures, patients who require insulin to manage their diabetes have resorted to illegal 
activities such as borrowing insulin, importing insulin from lower-cost countries, or purchasing insulin from 
illegitimate online sources.31 Our analysis, which focuses on the online pharmacy marketplace, 
demonstrates that among pharmacies that ship within the U.S., the cost of Humalog and NovoLog per mL 
from illegitimate online pharmacies (depending on product and dosage form) is approximately 2-5 times 
cheaper than that offered from legitimate online pharmacies or GoodRx, as outlined in  Figure 6. These 
substantial price differences raise concerns that illegitimate online pharmacies might appeal to patients 
priced out of traditional means of acquiring insulin. Thus, potentially making drastically lower insulin 
prices a useful indicator of pharmacy legitimacy. Beyond offering lower prices, rogue online pharmacies 
also employ marketing methods that might appeal to a cost-conscious consumer such as offering bulk 
discounts or coupons, as seen in Table 4. In addition, illegitimate pharmacies appeal to affordability through 
language on their homepages, as detailed in Table 5. 
 
Though costs are lower for Humalog and NovoLog from illegitimate online pharmacies, they remain illegal 
because there are serious risks associated with their use. Humalog and NovoLog are high-risk medications 
that require both therapeutic monitoring to ensure optimal short- and long-term outcomes and sufficient 
counseling for the prevention of adverse events like hypoglycemia. From 2007-2009, nearly 20% of 
emergency hospitalizations for treatment of emergent adverse events were due to insulin.46 The cost of these 
visits is not trivial—in 2016, the total mean cost per-person per-visit for hypoglycemia was $1,965 for an 
emergency department (ED) visit and $11,632 for an inpatient hospitalization.47 The American Diabetes 
Association (ADA) recommends that patients treated with insulin who are unaware of hypoglycemia should 
be counseled on signs and methods to treat.48  
 
Our analysis demonstrates that illegitimate online pharmacies—particularly rogue online pharmacies—do 
not offer pharmacy services on-par with those offered through legitimate online pharmacies, as outlined in 
Table 3. 90% of rogue online pharmacies that shipped within the U.S. allowed the purchase of Humalog or 
NovoLog without a prescription, precluding the involvement of healthcare professionals in patient care. 
Further preventing communication with healthcare professionals, no rogue online pharmacies made the 
offer to speak with a pharmacist. On rogue and unapproved online pharmacies, patients were often left 
without drug information and drug-related warnings and precautions (40% and 60% for both categories, 
respectively). Given these characteristics, illegitimate online pharmacies—with rogue online pharmacies 
being the worst offender—allow patients to access Humalog and NovoLog with minimal information, 
predisposing these patients to poor diabetes control and the potential development of adverse events.  
 
Limitations 
There were several limitations to our study. We limited our screening to 300 websites for each medication 
due to feasibility. Given this limitation, numerous online pharmacies remained undetected. This limited 
screening yielded, in the Adderall analysis, only one legitimate pharmacy, and in the insulin analysis, only 
three legitimate pharmacies that shipped within the U.S., precluding an in-depth analysis comparing the 
characteristics of rogue versus legitimate pharmacies. However, we believe that our methodology 
accurately replicates the behavior of a typical U.S. consumer who would only view the first few pages of 
search results. Though we were able to assess how many unique visits each online pharmacy received from 
www.SimilarWeb.com, it is not possible to determine how frequently the medications were viewed or 
purchased on each website. We did not attempt to purchase the medications from any of the included online 
pharmacies. It is therefore unclear whether an order placed with an online pharmacy included in this sample 
would have resulted in the delivery of the medication. Without purchasing the product, we also could not 
test the quality of the medication. However, we believe that the purchase of prescription drugs from rogue 
online pharmacies is in itself ethically tenuous. Though we believe our results are generally applicable to 
the online pharmacy landscape, given the transient nature of online pharmacies, our results—in terms of 
particular sites analyzed—are a slice-in-time, analyzing the sites listed on four search engines in the U.S. 
from September 2019 to February 2020. Our study also failed to capture the prevalence of medication 
advertising on social media platforms, which is an emerging market for the advertising and person-to-person 
sale of prescription drugs.49,50 Still, we hold that common search engines remain a relevant and easy access 
point for consumers to access websites selling controlled substances. Finally, data collection for our study 
was conducted prior to the COVID-19 pandemic, which saw an increase in rogue online pharmacies 
peddling no-prescription medications, particularly for treatment of COVID-19.51 Our results remain 
relevant and particularly important as online consumption of goods and prescription medications becomes 
commonplace, putting more consumers at risk to purchase from rogue online pharmacies.  
 
Conclusion 
Adderall, a controlled substance with high potential for abuse, and rapid-acting insulins, a high-risk class 
of medications, are readily accessible online without a prescription. While doing little to assure patient 
safety, illegitimate online pharmacies treat patients as consumers with aggressive marketing tactics. The 
relatively low cost of rapid-acting insulins places patients purchasing these medications at an even higher 
risk. Governmental agencies should continue to pursue legal and regulatory pressures with the intent to 
close illegitimate online pharmacies. Search engines should work to better filter their results, decreasing 
visibility of illegitimate online pharmacies. Finally, while public awareness campaigns and provider-to-
patient efforts can bring attention to the dangers of illegitimate online pharmacies, they do not address the 
reasons that patients might visit these sites. With patient safety in mind, legislators and members of the 
pharmaceutical supply chain should work to lower the cost of insulin, in effect diminishing patients’ 
incentive to purchase from illegitimate online pharmacies. 
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Figure 2 (Adderall). Monthly website traffic (unique visits) to online pharmacies selling Adderall  
 
 
Key: M—million, N—number 



































Table 1 (Adderall). Safety characteristics of online pharmacies selling Adderall stratified by rogue, 
unclassified, and legitimate pharmacies 
 
 Rogue (N = 50) Unclassified (N = 11) Legitimate (N = 1) Yes No Yes No NR Yes No NR 
Prescription required 0 50 (100%) 0 11 (100%) 0 1 (100%) 0 0 
Health-related 
Questionnaire required 0 50 (100%) 0 11 (100%) 0 0 1 (100%) 0 
Offer to speak with 
RPh 0 50 (100%) 0 11 (100%) 0 1 (100%) 0 0 
Drug precautions on 
product page 33 (66%) 17 (34%) 6 (55%) 4 (36%) 1 (9%) 0 0 1 (100%) 
Drug information on 
product page 45 (90%) 5 (10%) 9 (82%) 1 (9%) 1 (9%) 0 0 1 (100%) 
Quantity control 0 50 (100%) 0 11 (100%) 0 1 (100%) 0 0 
Location listed on 
website and location of 
server match 
8 (16%) 42 (84%) 4 (36%) 7 (64%) 0 1 (100%) 0 0 
 
Key: N—number, NR—not reported, RPh—pharmacist  
  
Figure 3 (Adderall). Rogue online pharmacies selling Adderall had server locations that seldom matched 
those claimed on the website 
 
  
Table 2 (Adderall). Marketing characteristics of online pharmacies selling Adderall stratified by rogue, 
unclassified, and legitimate pharmacies  
 
 Rogue (N = 50) Unclassified (N = 11) Legitimate (N = 1) Yes No Yes No NR Yes No NR 
Claims price discount 31 (62%) 19 (38%) 6 (55%) 5 (45%) 0 0 1 (100%) 0 
Bulk discounts 34 (68%) 16 (32%) 7 (64%) 4 (36%) 0 0 1 (100%) 0 
Coupon or promo code 35 (70%) 15 (30%) 8 (73%) 3 (27%) 0 0 0 1 (100%) 
Accepts cryptocurrency 37 (74%) 13 (26%) 8 (73%) 2 (18%) 1 (9%) 0 1 (100%) 0 
Adderall-specific ads 15 (30%) 35 (70%) 4 (36%) 7 (64%) 0 0 1 (100%) 0 
Ads for other products 
on page selling 
Adderall 
43 (86%) 7 (14%) 8 (73%) 2 (18%) 1 (9%) 0 0 1 (100%) 
Phone # or WhatsApp 41 (82%) 9 (18%) 9 (82%) 2 (18%) 0 1 (100%) 0 0 
Offer to speak with 
associate 49 (98%) 1 (2%) 11 (100%) 0 0 1 (100%) 0 0 
Registration claims 15 (30%) 35 (70%) 5 (45%) 6 (55%) 0 1 (100%) 0 0 
Customer testimonies 35 (70%) 15 (30%) 5 (45%) 6 (55%) 0 0 1 (100%) 0 
Privacy assurances 37 (74%) 13 (26%) 8 (73%) 3 (27%) 0 1 (100%) 0 0 
 
Key: N—number, NR—not reported 
  


































Table 3 (Insulin). Safety characteristics of online pharmacies selling Humalog or NovoLog in the U.S. 
 
 
Rogue (N = 10) Unapproved (N = 5) Legitimate (N = 3) 
Yes No Not Reported Yes No 
Not 
Reported Yes No 
Not 
Reported 
Prescription required 1 (10%) 9 (90%) 0 5 (100%) 0 0 3 (100%) 0 0 
Offer to speak with 
pharmacist 0 10 (100%) 0 3 (60%) 2 (40%) 0 2 (67%) 0 1 (33%)
a 
Drug precautions on 
product page 6 (60%) 4 (40%) 0 2 (40%) 3 (60%) 0 3 (100%) 0 0 
Drug information on 
product page 6 (60%) 4 (40%) 0 2 (40%) 3 (60%) 0 3 (100%) 0 0 
Quantity control 1 (10%) 9 (90%) 0 5 (100%) 0 0 3 (100%) 0 0 
Lists a physical 
location 3 (30%) 7 (70%) 0 5 (100%) 0 0 3 (100%) 0 0 
Location listed on 
website and location 
of server match 
0 10 (100%) 0 2 (40%) 3 (60%) 0 3 (100%) 0 0 
a One legitimate pharmacy required an account to gain access to services 
Five online pharmacies selling Humalog or NovoLog in the U.S. were not classified by LegitScript. 
  
Table 4 (Insulin). Marketing characteristics of online pharmacies selling Humalog or NovoLog 
 
 
Rogue (N = 18) Unapproved (N = 11) Legitimate (N = 7) 
Yes No Not Reported Yes No 
Not 
Reported Yes No 
Not 
Reported 
U.S. shipping of 
insulin 10 (56%) 8 (44%) 0 5 (45%) 6 (55%) 0 3 (43%) 4 (57%) 0 
Bulk discounts 11 (61%) 5 (28%) 2 (11%) 2 (18%) 8 (73%) 1 (9%) 2 (29%) 5 (71%) 0 
Coupons 9 (50%) 8 (44%) 1 (6%) 2 (18%) 9 (82%) 0 4 (57%) 3 (43%) 0 
Registration claims 8 (44%) 10 (56%) 0 10 (91%) 1 (9%) 0 6 (86%) 1 (14%) 0 
Privacy assurances 14 (78%) 4 (22%) 0 8 (73%) 3 (27%) 0 1 (14%) 6 (86%) 0 
Customer 
testimonies 10 (56%) 8 (44%) 0 7 (64%) 4 (36%) 0 3 (43%) 4 (57%) 0 
Offer to speak with 
associate 18 (100%) 0 0 9 (82%) 2 (18%) 0 6 (86%) 1 (14%) 0 
Phone number 7 (39%) 11 (61%) 0 11 (100%) 0 0 7 (100%) 0 0 
Insulin-specific ads 0 18 (100%) 0 3 (27%) 8 (73%) 0 0 7 (100%) 0 
Ads for other 
products on page 
selling insulin 
13 (72%) 5 (28%) 0 1 (9%) 10 (91%) 0 4 (57%) 1 (14%) 2 (29%) 
Illustrates marketing characteristics of 49 websites selling Humalog or Novolog.  
Thirteen online pharmacies selling Humalog or NovoLog were not classified by LegitScript. 
  
Table 5 (Insulin). Types of marketing language used on ‘Home Page’ of online pharmacies selling 
Humalog or NovoLog 
 
Characteristic Descriptor Illegitimate (N=29) Legitimate (N=7) No. (%) Selected Quote No. (%) Selected Quote 
Quality Language suggesting 
quality of medication or 
services 
24 (83%) “We guarantee that all 
[medications] for sale on this 
site are 100% genuine and 
extremely powerful.” 
2 (29%) “[We] offer you quality 
care…” 
Safety Language explicitly 
referring to the safety of 
drug products, online 
ordering platform, or 
other services 
19 (66%) “When it comes to your health, 
we know that safety is your 
number one concern. It’s ours 
too.” 
1 (14%) “Besides delivering medicines 
at your doorstep, we…help 
people use their medicines 




availability of staff to 
answer questions or 
remedy problems 
24 (83%) “24/7 customer support (we are 
always at your disposal!).” 
4 (57%) “Customer service: get answers 
to your questions.” 
Reputability Language suggesting 
renown in selling or 
accreditation to sell 
prescription drugs 
16 (55%) “[Our pharmacy] has a great 
reputation serving the 
community for 47 years and 
counting.” 
4 (57%) “Accredited & Certified in all 
50 states.” 
Affordability Language suggesting 
discounts or cheap 
prescription drugs 
24 (83%) “[We] provide the same insulin 
that’s available in the US 
except our prices are much 
lower, and we pass on the 
savings to you.” 
5 (71%) “At [our pharmacy], you can 
buy health products and 
medicines online at best 
discounts.” 
Convenience Language suggesting 
ease of online pharmacy 
use or prescription drug 
purchase; fast delivery or 
services that allow for 
time-saving 
22 (76%) “The process of payment 
through Bitcoin is simple. You 
need to go through only a few 
steps to quickly confirm and 
complete your order.” 
5 (71%) “You get the convenience of 
online shopping combined with 
the support and guidance of 
our dedicated team.” 
Quotes were taken from online pharmacy websites.  
  
Figure 6 (Insulin). Cost of Humalog and NovoLog pens in the U.S. varies depending on source 
 
 
a Prices obtained from GoodRx.com on April 30, 2020.  
b Costs averaged at each classification for Humalog pens (rogue N=4; unapproved N=4; unclassified N=3; legitimate 
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